Dicerna Pharmaceuticals, Inc. logo
Dicerna Pharmaceuticals, Inc. DRNA
$ 38.25 0.34%

Dicerna Pharmaceuticals, Inc. Financial Ratios 2011-2024 | DRNA

Annual Financial Ratios Dicerna Pharmaceuticals, Inc.

2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

P/E

-14.9 -11.1 -6.3 -3.5 -0.9 -2.1 -7.1 -41.3 - -

P/S

10.2 55.7 90.5 92.6 182.6 724.5 - - - -

EV/EBITDA

-14.4 -9.3 -8.3 -2.4 -0.6 -1.2 -7.2 -42.6 - -

PEG

-1.09 1.11 -0.11 0.13 -0.13 0.71 0.05 -0.55 - -

P/B

12.2 8.7 2.8 2.1 1.3 1.5 3.5 -11.1 - -

P/CF

10.3 -189.1 31.2 -4.6 -1.1 -2.7 -9.3 -67.3 - -

ROE %

-81.85 -79.15 -44.27 -59.31 -144.42 -69.04 -48.75 26.87 - -

ROA %

-15.93 -20.16 -21.72 -49.67 -116.12 -62.82 -46.27 -37.19 - -

ROCE %

-21.36 -36.04 -19.44 -58.12 -144.99 -69.24 -45.81 -41.26 - -

DSO

80.1 3085.7 5958.1 383.4 707.7 105.1 - - - -

DIO

- - - - - - - - - -

DPO

- - - - - - - - - -

All numbers in USD currency